Citius Pharmaceuticals Inc (NASDAQ:CTXR) Insider Trading Activity – CEO Bought 558,597 shares of Stock

Insider Trading Activity For Citius Pharmaceuticals Inc (NASDAQ:CTXR)

Story continues below

Myron Z Holubiak , CEO of Citius Pharmaceuticals Inc (NASDAQ:CTXR) reportedly Bought 558,597 shares of the company’s stock at an average price of 0.9 for a total transaction amount of $502,737.30 SEC Form

Insider Trading History For Citius Pharmaceuticals Inc (NASDAQ:CTXR)

  • On 8/8/2017 Leonard L Mazur, Insider, bought 421,400 with an average share price of $4.13 per share and the total transaction amounting to $1,740,382.00.
  • On 8/24/2017 Leonard L Mazur, Insider, bought 11,000 with an average share price of $2.68 per share and the total transaction amounting to $29,480.00.
  • On 3/28/2018 Myron Z Holubiak, Insider, bought 2,915 with an average share price of $3.09 per share and the total transaction amounting to $9,007.35.
  • On 8/13/2018 Myron Z Holubiak, Insider, bought 784,314 with an average share price of $1.28 per share and the total transaction amounting to $1,003,921.92.
  • On 4/3/2019 Myron Z Holubiak, Insider, bought 129,450 with an average share price of $1.55 per share and the total transaction amounting to $200,647.50.
  • On 4/3/2019 Leonard L Mazur, Major Shareholder, bought 1,165,048 with an average share price of $1.55 per share and the total transaction amounting to $1,805,824.40.
  • On 9/27/2019 Myron Z Holubiak, CEO, bought 558,597 with an average share price of $0.90 per share and the total transaction amounting to $502,737.30.
  • Analyst Ratings History For Citius Pharmaceuticals Inc (NASDAQ:CTXR)

    • On 2/7/2019 HC Wainwright Reiterated Rating Buy with a price target of $3.00
    • On 9/6/2019 Dawson James Initiated Coverage of rating Buy with a price target of $7.00

    Recent Trading Activity for Citius Pharmaceuticals Inc (NASDAQ:CTXR)
    Shares of Citius Pharmaceuticals Inc closed the previous trading session at 0.74 up +0.020 2.74% with 98652 shares trading hands.

    An ad to help with our costs